Turning to GlycoFi's technology should enable Merck to morerapidlydevelop drugs that may require less frequent dosage and potentially have better overall performance.
Developers will be able to leverage the reference designs to rapidlydevelop their own virtual assistant capabilities for travel, insurance, retail, government and more.